Bridgeway Capital Management, LLC Innoviva, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 325,154 shares of INVA stock, worth $5.78 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
325,154
Previous 558,276 41.76%
Holding current value
$5.78 Million
Previous $9.16 Million 31.46%
% of portfolio
0.14%
Previous 0.22%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$16.33 - $20.04 $3.81 Million - $4.67 Million
-233,122 Reduced 41.76%
325,154 $6.28 Million
Q2 2024

Aug 14, 2024
BUY
$14.4 - $16.4 $277,344 - $315,864
19,260 Added 3.57%
558,276 $9.16 Million
Q1 2024

May 15, 2024
BUY
$14.56 - $16.78 $275,038 - $316,974
18,890 Added 3.63%
539,016 $8.21 Million
Q4 2023

Feb 14, 2024
BUY
$12.32 - $16.27 $256,514 - $338,757
20,821 Added 4.17%
520,126 $8.34 Million
Q3 2023

Nov 14, 2023
BUY
$12.37 - $13.89 $213,036 - $239,213
17,222 Added 3.57%
499,305 $6.49 Million
Q2 2023

Aug 14, 2023
BUY
$11.39 - $13.72 $76,973 - $92,719
6,758 Added 1.42%
482,083 $6.14 Million
Q1 2023

May 15, 2023
BUY
$10.73 - $13.6 $1.4 Million - $1.77 Million
130,145 Added 37.7%
475,325 $5.35 Million
Q4 2022

Feb 14, 2023
BUY
$11.8 - $13.78 $2.24 Million - $2.61 Million
189,680 Added 121.98%
345,180 $4.57 Million
Q3 2021

Nov 15, 2021
BUY
$13.06 - $17.24 $1.86 Million - $2.45 Million
142,100 Added 1060.45%
155,500 $2.6 Million
Q2 2021

Aug 16, 2021
SELL
$11.45 - $13.96 $297,700 - $362,960
-26,000 Reduced 65.99%
13,400 $180,000
Q1 2021

May 17, 2021
BUY
$11.06 - $12.87 $66,360 - $77,220
6,000 Added 17.96%
39,400 $471,000
Q4 2020

Feb 16, 2021
BUY
$9.33 - $12.48 $36,387 - $48,672
3,900 Added 13.22%
33,400 $414,000
Q3 2020

Nov 16, 2020
BUY
$10.33 - $14.49 $28,924 - $40,572
2,800 Added 10.49%
29,500 $308,000
Q2 2020

Aug 14, 2020
SELL
$11.49 - $15.26 $47,109 - $62,566
-4,100 Reduced 13.31%
26,700 $373,000
Q1 2020

May 15, 2020
SELL
$8.11 - $15.23 $53,525 - $100,518
-6,600 Reduced 17.65%
30,800 $362,000
Q4 2019

Feb 14, 2020
SELL
$10.28 - $14.38 $83,268 - $116,478
-8,100 Reduced 17.8%
37,400 $530,000
Q3 2019

Nov 14, 2019
SELL
$10.05 - $14.55 $51,255 - $74,205
-5,100 Reduced 10.08%
45,500 $480,000
Q2 2019

Aug 14, 2019
BUY
$13.1 - $14.95 $662,860 - $756,470
50,600 New
50,600 $737,000

Others Institutions Holding INVA

# of Institutions
227
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email